[8-K] Catheter Precision, Inc. Reports Material Event
Catheter Precision, Inc. furnished a Current Report on Form 8-K to announce that it issued a press release on August 11, 2025 reporting its financial results for the three and six months ended June 30, 2025. The company states the full press release is attached as Exhibit 99.1 and is incorporated by reference into the report. The company also clarifies that the information furnished under Item 2.02, including Exhibit 99.1, is being furnished and not filed for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into future SEC filings unless expressly stated.
Catheter Precision, Inc. ha presentato un Current Report sul Modulo 8-K per comunicare di aver diffuso un comunicato stampa l'11 agosto 2025 relativo ai risultati finanziari per i tre e sei mesi conclusisi il 30 giugno 2025. La societ脿 dichiara che il comunicato integrale 猫 allegato come Exhibit 99.1 e viene incorporato per riferimento nel rapporto. Inoltre, precisa che le informazioni fornite ai sensi dell'Item 2.02, inclusa l'Exhibit 99.1, sono fornite e non depositate ai fini della Sezione 18 dell'Exchange Act e non saranno incorporate per riferimento in future filing presso la SEC salvo diversa indicazione esplicita.
Catheter Precision, Inc. present贸 un Current Report en el Formulario 8-K para anunciar que emiti贸 un comunicado de prensa el 11 de agosto de 2025 con sus resultados financieros correspondientes a los tres y seis meses terminados el 30 de junio de 2025. La compa帽铆a indica que el comunicado completo se adjunta como Exhibit 99.1 y se incorpora por referencia al informe. Adem谩s, aclara que la informaci贸n suministrada bajo el Item 2.02, incluida la Exhibit 99.1, se aporta como informaci贸n y no se presenta a efectos de la Secci贸n 18 del Exchange Act, y no se incorporar谩 por referencia en futuros documentos ante la SEC salvo que se indique expresamente lo contrario.
Catheter Precision, Inc.電� 2025雲� 8鞗� 11鞚检瀽搿� 2025雲� 6鞗� 30鞚茧 毵堦皭霅� 3臧滌洈 氚� 6臧滌洈鞚� 鞛鞁れ爜鞚� 氤搓碃頃橂姅 氤措弰鞛愲毳� 氚滍憸頄堨潓鞚� 鞎岆Μ旮� 鞙勴暣 Form 8-K 順勳灛 氤搓碃靹滊ゼ 鞝滌稖頄堨姷雼堧嫟. 須岇偓電� 鞝勳泊 氤措弰鞛愲臧� Exhibit 99.1搿� 觳秬霅橃柎 氤搓碃靹滌棎 彀胳“搿� 韽暔霅橃柎 鞛堧嫟瓿� 氚濏様鞀惦媹雼�. 霕愴暅 Item 2.02鞐� 霐半澕 鞝滉车霅� 鞝曤炒(Exhibit 99.1 韽暔)電� 鞝滌稖(filing)鞚� 鞎勲媹霛� 鞝滉车(furnishing)霅橂姅 瓴冹澊氅�, Exchange Act 靹轨厴 18鞚� 氇╈爜靸� 鞝滌稖霅橂姅 瓴冹澊 鞎勲媹瓿� 氇呾嫓鞝侅溂搿� 旮办灛霅橃 鞎婋姅 頃� 頄ロ泟 SEC 鞝滌稖 氍胳劀鞐� 彀胳“搿� 韽暔霅橃 鞎婌潉 瓴冹瀯鞚� 氇呿檿頌� 頄堨姷雼堧嫟.
Catheter Precision, Inc. a d茅pos茅 un Current Report sur le formulaire 8鈥慘 pour annoncer qu'elle avait publi茅 un communiqu茅 de presse le 11 ao没t 2025 faisant 茅tat de ses r茅sultats financiers pour les trois et six mois clos le 30 juin 2025. La soci茅t茅 indique que le communiqu茅 complet est joint en tant qu'Exhibit 99.1 et est incorpor茅 par renvoi dans le rapport. Elle pr茅cise 茅galement que les informations fournies en vertu de l'Item 2.02, y compris l'Exhibit 99.1, sont fournies et non d茅pos茅es aux fins de la Section 18 du Exchange Act et ne seront pas incorpor茅es par renvoi dans de futurs d茅p么ts aupr猫s de la SEC sauf indication expresse contraire.
Catheter Precision, Inc. hat einen Current Report auf Formular 8-K eingereicht, um mitzuteilen, dass es am 11. August 2025 eine Pressemitteilung ver枚ffentlicht hat, in der die Finanzergebnisse f眉r die drei bzw. sechs Monate zum 30. Juni 2025 berichtet werden. Das Unternehmen erkl盲rt, dass die vollst盲ndige Pressemitteilung als Exhibit 99.1 beigef眉gt und durch Verweisung in den Bericht eingearbeitet ist. Au脽erdem stellt das Unternehmen klar, dass die gem盲脽 Item 2.02 bereitgestellten Informationen, einschlie脽lich Exhibit 99.1, zur Verf眉gung gestellt und nicht im Sinne von Abschnitt 18 des Exchange Act eingereicht werden und nicht ohne ausdr眉ckliche Erkl盲rung in k眉nftige SEC-Einreichungen einbezogen werden.
- None.
- None.
Insights
TL;DR Routine earnings release furnished; no financial figures provided in the 8-K itself, so investor impact is unclear.
The filing notifies investors that a press release containing Q2 and year-to-date results was issued and attached as Exhibit 99.1. Because the 8-K only furnishes the press release and explicitly states the information is not "filed," the disclosure is procedural rather than providing substantive numbers within the filing. Analysts must review Exhibit 99.1 to assess revenue, profit, cash flow, or changes in guidance. As presented, the 8-K confirms timely disclosure under Item 2.02 but does not by itself change the financial picture.
TL;DR The company followed Form 8-K practice by furnishing its earnings press release and clarifying filing status.
The 8-K appropriately identifies the press release as Exhibit 99.1 and states the information is being "furnished" not "filed," limiting legal incorporation into other SEC filings. This is standard practice to provide timely investor communication while managing legal exposure. No governance or compliance issues are apparent from the text provided; however, material content and any forward-looking statements must be reviewed within the attached press release for further assessment.
Catheter Precision, Inc. ha presentato un Current Report sul Modulo 8-K per comunicare di aver diffuso un comunicato stampa l'11 agosto 2025 relativo ai risultati finanziari per i tre e sei mesi conclusisi il 30 giugno 2025. La societ脿 dichiara che il comunicato integrale 猫 allegato come Exhibit 99.1 e viene incorporato per riferimento nel rapporto. Inoltre, precisa che le informazioni fornite ai sensi dell'Item 2.02, inclusa l'Exhibit 99.1, sono fornite e non depositate ai fini della Sezione 18 dell'Exchange Act e non saranno incorporate per riferimento in future filing presso la SEC salvo diversa indicazione esplicita.
Catheter Precision, Inc. present贸 un Current Report en el Formulario 8-K para anunciar que emiti贸 un comunicado de prensa el 11 de agosto de 2025 con sus resultados financieros correspondientes a los tres y seis meses terminados el 30 de junio de 2025. La compa帽铆a indica que el comunicado completo se adjunta como Exhibit 99.1 y se incorpora por referencia al informe. Adem谩s, aclara que la informaci贸n suministrada bajo el Item 2.02, incluida la Exhibit 99.1, se aporta como informaci贸n y no se presenta a efectos de la Secci贸n 18 del Exchange Act, y no se incorporar谩 por referencia en futuros documentos ante la SEC salvo que se indique expresamente lo contrario.
Catheter Precision, Inc.電� 2025雲� 8鞗� 11鞚检瀽搿� 2025雲� 6鞗� 30鞚茧 毵堦皭霅� 3臧滌洈 氚� 6臧滌洈鞚� 鞛鞁れ爜鞚� 氤搓碃頃橂姅 氤措弰鞛愲毳� 氚滍憸頄堨潓鞚� 鞎岆Μ旮� 鞙勴暣 Form 8-K 順勳灛 氤搓碃靹滊ゼ 鞝滌稖頄堨姷雼堧嫟. 須岇偓電� 鞝勳泊 氤措弰鞛愲臧� Exhibit 99.1搿� 觳秬霅橃柎 氤搓碃靹滌棎 彀胳“搿� 韽暔霅橃柎 鞛堧嫟瓿� 氚濏様鞀惦媹雼�. 霕愴暅 Item 2.02鞐� 霐半澕 鞝滉车霅� 鞝曤炒(Exhibit 99.1 韽暔)電� 鞝滌稖(filing)鞚� 鞎勲媹霛� 鞝滉车(furnishing)霅橂姅 瓴冹澊氅�, Exchange Act 靹轨厴 18鞚� 氇╈爜靸� 鞝滌稖霅橂姅 瓴冹澊 鞎勲媹瓿� 氇呾嫓鞝侅溂搿� 旮办灛霅橃 鞎婋姅 頃� 頄ロ泟 SEC 鞝滌稖 氍胳劀鞐� 彀胳“搿� 韽暔霅橃 鞎婌潉 瓴冹瀯鞚� 氇呿檿頌� 頄堨姷雼堧嫟.
Catheter Precision, Inc. a d茅pos茅 un Current Report sur le formulaire 8鈥慘 pour annoncer qu'elle avait publi茅 un communiqu茅 de presse le 11 ao没t 2025 faisant 茅tat de ses r茅sultats financiers pour les trois et six mois clos le 30 juin 2025. La soci茅t茅 indique que le communiqu茅 complet est joint en tant qu'Exhibit 99.1 et est incorpor茅 par renvoi dans le rapport. Elle pr茅cise 茅galement que les informations fournies en vertu de l'Item 2.02, y compris l'Exhibit 99.1, sont fournies et non d茅pos茅es aux fins de la Section 18 du Exchange Act et ne seront pas incorpor茅es par renvoi dans de futurs d茅p么ts aupr猫s de la SEC sauf indication expresse contraire.
Catheter Precision, Inc. hat einen Current Report auf Formular 8-K eingereicht, um mitzuteilen, dass es am 11. August 2025 eine Pressemitteilung ver枚ffentlicht hat, in der die Finanzergebnisse f眉r die drei bzw. sechs Monate zum 30. Juni 2025 berichtet werden. Das Unternehmen erkl盲rt, dass die vollst盲ndige Pressemitteilung als Exhibit 99.1 beigef眉gt und durch Verweisung in den Bericht eingearbeitet ist. Au脽erdem stellt das Unternehmen klar, dass die gem盲脽 Item 2.02 bereitgestellten Informationen, einschlie脽lich Exhibit 99.1, zur Verf眉gung gestellt und nicht im Sinne von Abschnitt 18 des Exchange Act eingereicht werden und nicht ohne ausdr眉ckliche Erkl盲rung in k眉nftige SEC-Einreichungen einbezogen werden.
FAQ
What did Catheter Precision (VTAK) disclose in this 8-K?
Does the 8-K include the actual financial numbers for Q2 2025?
Is the information in Item 2.02 considered "filed" with the SEC?
Where can investors find the press release referenced in the 8-K?
Does this 8-K indicate any other material events or transactions?
